Literature DB >> 9278481

Kinetics of phosphorothioate oligonucleotide metabolism in biological fluids.

M Gilar1, A Belenky, D L Smisek, A Bourque, A S Cohen.   

Abstract

The in vitro stability and metabolism of GEM[91, a 25mer phosphorothioate antisense oligonucleotide complementary to the gag mRNA region of HIV-1, was investigated using capillary electrophoresis (CE). The in vitro degradation of the parent compound at 37 degrees C was followed over the course of 120 h in human plasma. A CE method using laser-induced fluorescence detection was able to detect 5'-end intact metabolites including the parent compound extracted from biological fluids. Because the primary metabolic pathway is believed to be via 3'-exonuclease activity, the results of this study were compared with the stability of the compound in a solution containing 3'-exonuclease. The numerical solution of sequential first-order reactions was used to obtain kinetic parameters. Exonuclease digestion of the parent compound, as measured using an automated CE-UV instrument, yielded striking similarities between the two in vitro systems as well as between in vitro and in vivo systems.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278481      PMCID: PMC146928          DOI: 10.1093/nar/25.18.3615

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  9 in total

Review 1.  Antisense oligonucleotides: towards clinical trials.

Authors:  S Agrawal
Journal:  Trends Biotechnol       Date:  1996-10       Impact factor: 19.536

2.  A nonradioisotope approach to study the in vivo metabolism of phosphorothioate oligonucleotides.

Authors:  A S Cohen; A J Bourque; B H Wang; D L Smisek; A Belenky
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1997-02

3.  Pharmacokinetic properties of several novel oligonucleotide analogs in mice.

Authors:  S T Crooke; M J Graham; J E Zuckerman; D Brooks; B S Conklin; L L Cummins; M J Greig; C J Guinosso; D Kornbrust; M Manoharan; H M Sasmor; T Schleich; K L Tivel; R H Griffey
Journal:  J Pharmacol Exp Ther       Date:  1996-05       Impact factor: 4.030

Review 4.  Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides.

Authors:  S K Srinivasan; P Iversen
Journal:  J Clin Lab Anal       Date:  1995       Impact factor: 2.352

5.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Authors:  P C Zamecnik; M L Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

6.  Bond order and charge localization in nucleoside phosphorothioates.

Authors:  P A Frey; R D Sammons
Journal:  Science       Date:  1985-05-03       Impact factor: 47.728

7.  Inhibition of replication and expression of human T-cell lymphotropic virus type III in cultured cells by exogenous synthetic oligonucleotides complementary to viral RNA.

Authors:  P C Zamecnik; J Goodchild; Y Taguchi; P S Sarin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

8.  Pharmacokinetics of an anti-human immunodeficiency virus antisense oligodeoxynucleotide phosphorothioate (GEM 91) in HIV-infected subjects.

Authors:  R Zhang; J Yan; H K Shahinian; H Shahinian; G Amin; Z Lu; T Liu; M S Saag; Z Jiang; J Temsamani; R R Martin
Journal:  Clin Pharmacol Ther       Date:  1995-07       Impact factor: 6.875

9.  Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1.

Authors:  R Zhang; R B Diasio; Z Lu; T Liu; Z Jiang; W M Galbraith; S Agrawal
Journal:  Biochem Pharmacol       Date:  1995-03-30       Impact factor: 5.858

  9 in total
  13 in total

1.  Separation of peptide fragments of a protein kinase C substrate fused to a β-hairpin by capillary electrophoresis.

Authors:  Imola G Zigoneanu; Christopher E Sims; Nancy L Allbritton
Journal:  Anal Bioanal Chem       Date:  2015-10-01       Impact factor: 4.142

2.  DETECTING LOW-LEVEL SYNTHESIS IMPURITIES IN MODIFIED PHOSPHOROTHIOATE OLIGONUCLEOTIDES USING LIQUID CHROMATOGRAPHY - HIGH RESOLUTION MASS SPECTROMETRY.

Authors:  Irena Nikcevic; Tadeusz K Wyrzykiewicz; Patrick A Limbach
Journal:  Int J Mass Spectrom       Date:  2011-07-01       Impact factor: 1.986

3.  A Novel and Intuitive Method of Displaying and Interacting with Mass Difference Information: Application to Oligonucleotide Drug Impurities.

Authors:  Stilianos G Roussis
Journal:  J Am Soc Mass Spectrom       Date:  2015-04-03       Impact factor: 3.109

4.  Oligonucleotide analysis by hydrophilic interaction liquid chromatography-mass spectrometry in the absence of ion-pair reagents.

Authors:  Peter A Lobue; Manasses Jora; Balasubrahmanyam Addepalli; Patrick A Limbach
Journal:  J Chromatogr A       Date:  2019-02-07       Impact factor: 4.759

5.  Histidine triad nucleotide-binding protein 1 (HINT-1) phosphoramidase transforms nucleoside 5'-O-phosphorothioates to nucleoside 5'-O-phosphates.

Authors:  Magdalena Ozga; Rafal Dolot; Magdalena Janicka; Renata Kaczmarek; Agnieszka Krakowiak
Journal:  J Biol Chem       Date:  2010-10-12       Impact factor: 5.157

Review 6.  Current Status of Antisense Oligonucleotide-Based Therapy in Neuromuscular Disorders.

Authors:  Flavien Bizot; Adeline Vulin; Aurélie Goyenvalle
Journal:  Drugs       Date:  2020-09       Impact factor: 9.546

7.  Comparison of the cleavage profiles of oligonucleotide duplexes with or without phosphorothioate linkages by using a chemical nuclease probe.

Authors:  A Chworos; P Arnaud; K Zakrzewska; P Guga; G Pratviel; W Stec; B Meunier
Journal:  J Biol Inorg Chem       Date:  2004-03-19       Impact factor: 3.358

Review 8.  In vivo and in vitro studies of antisense oligonucleotides - a review.

Authors:  Anna Kilanowska; Sylwia Studzińska
Journal:  RSC Adv       Date:  2020-09-17       Impact factor: 4.036

Review 9.  The Use of Tricyclo-DNA Oligomers for the Treatment of Genetic Disorders.

Authors:  Philippine Aupy; Lucía Echevarría; Karima Relizani; Aurélie Goyenvalle
Journal:  Biomedicines       Date:  2017-12-22

Review 10.  Recent developments in the characterization of nucleic acids by liquid chromatography, capillary electrophoresis, ion mobility, and mass spectrometry (2010-2020).

Authors:  Inês C Santos; Jennifer S Brodbelt
Journal:  J Sep Sci       Date:  2020-10-15       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.